A Study for Patients With Type 2 Diabetes

NCT01027871 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

289

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY2605541
DRUG: insulin glargine

Sponsor

Eli Lilly and Company